Saturday, 31 October 2026European Markets

THE NAVIGATOR COMP, JACQUET METALS, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Basic Materials Sector.

Loading stream...

(vianews) - the navigator comp (nvg.ls) is among this list of stock assets with the highest dividend rate and return on equity on the basic materials sector.

financial asset price forward dividend yield return on equity
the navigator comp (nvg.ls) €3.80 17.54% 31.56%
jacquet metals (jcq.pa) €18.02 6.68% 16.73%
robertet (rbt.pa) €817.00 1.04% 13.85%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. the navigator comp (nvg.ls)

17.54% forward dividend yield and 31.56% return on equity

the navigator company, s.a. manufactures and markets pulp and paper products worldwide. the company operates through market pulp, uwf paper, tissue paper, and biomass renewable energy segments. it produces bleached eucalyptus kraft pulp, uncoated writing and printing thin paper, and domestic consumption paper under the navigator, multioffice, discovery, explorer, inacopia, target, pioneer, soporset, inaset, and target plus brands for professional and home use. the company also operates cogeneration units and two independent thermoelectric power plants. the company was formerly known as portucel, s.a. and changed its name to the navigator company, s.a. in february 2016. the navigator company, s.a. was founded in 1953 and is headquartered in setúbal, portugal. the navigator company, s.a. operates as a subsidiary of semapa - sociedade de investimento e gestão, sgps, s.a.

earnings per share

as for profitability, the navigator comp has a trailing twelve months eps of €0.45.

pe ratio

the navigator comp has a trailing twelve months price to earnings ratio of 8.44. meaning, the purchaser of the share is investing €8.44 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.56%.

moving average

the navigator comp's value is way higher than its 50-day moving average of €3.16 and way higher than its 200-day moving average of €3.35.

volume

today's last reported volume for the navigator comp is 303632 which is 41.26% below its average volume of 516942.

growth estimates quarters

the company's growth estimates for the ongoing quarter and the next is a negative 53.3% and a negative 76.5%, respectively.

more news about the navigator comp.

2. jacquet metals (jcq.pa)

6.68% forward dividend yield and 16.73% return on equity

jacquet metals sa engages in the buying and trading of special metals in france, europe, asia, and north america. it operates through three divisions: jacquet, stappert, and ims group. the company distributes stainless-steel quarto plates, which are used in water, environment, energy, mechanical and forged metal construction, chemical and agri-food, gas processing and storage, pharmaceutical, and cosmetic sectors. it also distributes long stainless-steel products in the form of bars, profiles, welded tubes, and fittings that are used in the agri-food, chemical, petrochemical, pipefitting, energy, transport, and decoration sectors. in addition, the company distributes carbon, alloy, and stainless-steel engineering steels, and tool steels used in mechanical engineering, public works machinery, agricultural machinery, lifting machinery, car and hgv suppliers, and energy sectors. jacquet metals sa was founded in 1962 and is based in saint-priest, france.

earnings per share

as for profitability, jacquet metals has a trailing twelve months eps of €3.04.

pe ratio

jacquet metals has a trailing twelve months price to earnings ratio of 5.93. meaning, the purchaser of the share is investing €5.93 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.73%.

volatility

jacquet metals's last week, last month's, and last quarter's current intraday variation average was a negative 0.09%, a negative 0.23%, and a positive 1.20%.

jacquet metals's highest amplitude of average volatility was 0.42% (last week), 0.91% (last month), and 1.20% (last quarter).

yearly top and bottom value

jacquet metals's stock is valued at €18.02 at 01:30 est, way below its 52-week high of €20.05 and way higher than its 52-week low of €14.68.

more news about jacquet metals.

3. robertet (rbt.pa)

1.04% forward dividend yield and 13.85% return on equity

robertet sa produces and sells perfumes, aromas, and natural products. the company operates in four segments: raw materials, fragrances, flavors, and active ingredients. it also produces organic essential oils and active ingredients. the company operates in north america, europe, the asia pacific, south america, caribbean, africa, and the middle east. robertet sa was founded in 1850 and is headquartered in grasse, france.

earnings per share

as for profitability, robertet has a trailing twelve months eps of €36.02.

pe ratio

robertet has a trailing twelve months price to earnings ratio of 22.68. meaning, the purchaser of the share is investing €22.68 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.85%.

more news about robertet.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com